167 related articles for article (PubMed ID: 22460160)
1. Cognitive impairment in degenerative parkinsonisms: role of radionuclide brain imaging.
Arnaldi D; Morbelli S; Morrone E; Campus C; Nobili F
Q J Nucl Med Mol Imaging; 2012 Feb; 56(1):55-67. PubMed ID: 22460160
[TBL] [Abstract][Full Text] [Related]
2. Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD).
Nobili F; Morbelli S; Arnaldi D; Ferrara M; Campus C; Brugnolo A; Mazzei D; Mehrdad N; Sambuceti G; Rodriguez G
J Neurol Sci; 2011 Nov; 310(1-2):31-5. PubMed ID: 21762928
[TBL] [Abstract][Full Text] [Related]
3. [Cognitive impairment in Parkinson's disease].
Tachibana H
Seishin Shinkeigaku Zasshi; 2013; 115(11):1142-9. PubMed ID: 24450147
[TBL] [Abstract][Full Text] [Related]
4. Neuroimaging in Parkinsonian Disorders.
Tripathi M; Kumar A; Bal C
Neurol India; 2018; 66(Supplement):S68-S78. PubMed ID: 29503329
[TBL] [Abstract][Full Text] [Related]
5. Update on SPECT and PET in parkinsonism - part 2: biomarker imaging of cognitive impairment in Lewy-body diseases.
Meyer PT; Frings L; Hellwig S
Curr Opin Neurol; 2014 Aug; 27(4):398-404. PubMed ID: 24978635
[TBL] [Abstract][Full Text] [Related]
6. Functional brain imaging of cognitive dysfunction in Parkinson's disease.
Hirano S; Shinotoh H; Eidelberg D
J Neurol Neurosurg Psychiatry; 2012 Oct; 83(10):963-9. PubMed ID: 22807560
[TBL] [Abstract][Full Text] [Related]
7. The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration.
Cummings JL; Henchcliffe C; Schaier S; Simuni T; Waxman A; Kemp P
Brain; 2011 Nov; 134(Pt 11):3146-66. PubMed ID: 21810889
[TBL] [Abstract][Full Text] [Related]
8. What causes mental dysfunction in Parkinson's disease?
Emre M
Mov Disord; 2003 Sep; 18 Suppl 6():S63-71. PubMed ID: 14502658
[TBL] [Abstract][Full Text] [Related]
9. Imaging of neurodegenerative cognitive and behavioral disorders: practical considerations for dementia clinical practice.
Atri A
Handb Clin Neurol; 2016; 136():971-84. PubMed ID: 27430453
[TBL] [Abstract][Full Text] [Related]
10. Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease.
Siepel FJ; Brønnick KS; Booij J; Ravina BM; Lebedev AV; Pereira JB; Grüner R; Aarsland D
Mov Disord; 2014 Dec; 29(14):1802-8. PubMed ID: 25284687
[TBL] [Abstract][Full Text] [Related]
11. Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo.
Klein JC; Eggers C; Kalbe E; Weisenbach S; Hohmann C; Vollmar S; Baudrexel S; Diederich NJ; Heiss WD; Hilker R
Neurology; 2010 Mar; 74(11):885-92. PubMed ID: 20181924
[TBL] [Abstract][Full Text] [Related]
12. Radioligand imaging of α4β2* nicotinic acetylcholine receptors in Alzheimer's disease and Parkinson's disease.
Meyer PM; Tiepolt S; Barthel H; Hesse S; Sabri O
Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):376-86. PubMed ID: 25387119
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic tool.
Nicastro N; Nencha U; Burkhard PR; Garibotto V
J Neurochem; 2023 Feb; 164(3):346-363. PubMed ID: 34935143
[TBL] [Abstract][Full Text] [Related]
14. Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson's disease.
Polito C; Berti V; Ramat S; Vanzi E; De Cristofaro MT; Pellicanò G; Mungai F; Marini P; Formiconi AR; Sorbi S; Pupi A
Neurobiol Aging; 2012 Jan; 33(1):206.e29-39. PubMed ID: 20961661
[TBL] [Abstract][Full Text] [Related]
15. Molecular imaging of dementia.
Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
[TBL] [Abstract][Full Text] [Related]
16. Imaging Familial and Sporadic Neurodegenerative Disorders Associated with Parkinsonism.
Brooks DJ
Neurotherapeutics; 2021 Apr; 18(2):753-771. PubMed ID: 33432494
[TBL] [Abstract][Full Text] [Related]
17. [Parkinson syndrome and cognitive disorders].
Szirmai I; Kovács T
Ideggyogy Sz; 2002 Jul; 55(7-8):220-5. PubMed ID: 12201229
[TBL] [Abstract][Full Text] [Related]
18. Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment.
Lyoo CH; Jeong Y; Ryu YH; Rinne JO; Lee MS
Eur Neurol; 2010; 64(2):65-73. PubMed ID: 20606450
[TBL] [Abstract][Full Text] [Related]
19. The role of molecular imaging in the differential diagnosis of parkinsonism.
Booij J; Teune LK; Verberne HJ
Q J Nucl Med Mol Imaging; 2012 Feb; 56(1):17-26. PubMed ID: 22460157
[TBL] [Abstract][Full Text] [Related]
20. Recent Advancement and Clinical Implications of 18FDG-PET in Parkinson's Disease, Atypical Parkinsonisms, and Other Movement Disorders.
Peralta C; Biafore F; Depetris TS; Bastianello M
Curr Neurol Neurosci Rep; 2019 Jun; 19(8):56. PubMed ID: 31256288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
